Assessment of variceal pressure by continuous non-invasive endoscopic registration: A placebo controlled evaluation of the effect of terlipressin and octreotide

Gut

Volumn 38, Issue 1, 1996, Pages 129-134

  Nevens, F ^a   Van Steenbergen, W ^a   Yap, S H ^a   Fevery, J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Octreotide; Portal hypertension; Terlipressin; Variceal bleeding; Variceal pressure

Indexed keywords

OCTREOTIDE; PLACEBO; TERLIPRESSIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOSCOPY; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030031571     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.38.1.129     Document Type: Article

References (24)

1. Garcia Tsao G, Groszmann RJ, Fisher RL, Conn HO, Attenburg CE, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985; 5: 419-24.
2. Rigau J, Bosch J, Bordas JM, Navasa M, Mastai R, Kravetz D, et al. Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage. Gastroenterology 1989; 96: 873-80.
3. Ruiz del Arhol L, Arocena C, Vazquez M, Defarges V, Maroño E, Garcia Plaza A, et al. Endoscopic measurement of variceal pressure (VP) during haemorrhage from esophageal varices (HVE). J Hepatol 1992; 16: S36.
4. Feu F, Bordas JM, Luca A, García-Pagán JC, Escorsell A, Bosch J, et al. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood glow in patients with cirrhosis. Hepatology 1993; 18: 1082-9.
5. Feu F, Bordas JM, García-Pagán JC, Bosch J, Rodés J. Double-blind investigation of the effects of propranolol and placebo on the pressure of esophageal varices in patients with portal hypertension. Hepatology 1991; 13: 917-22.
6. Nevens F, Sprengers D, Fevery J. The effect of different doses of a bolus injection of somatostatin combined with a slow infusion on transmural oesophageal variceal pressure in patients with cirrhosis. J Hepatol 1994; 20: 27-31.
7. Walker S, Stiehl A, Raedsch R, Kommerell B. Terlipressin in bleeding eosphageal varices. A placebo controlled double-blind study. Hepatology 1986; 6: 112-5.
8. Freeman JG, Cobden MD, Record CO. Placebo-controlled trial of terlipressin (Glypressin) in the management of acute variceal bleeding. J Clin Gastroenterol 1989; 11: 58-60.
9. Soderlund C, Magnusson I, Torngren S, Lundell L. Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol 1990; 25: 622-30.
10. Cestari R, Braga M, Missale G, Ravelli P, Burroughs AK. Haemodynamic effect of triglycyl-lysine-vasopressin (glypressin) on intravascular oesophageal variceal pressure in patients with cirrhosis. A randomized placebo controlled trial. J Hepatol 1990; 10: 205-10.
11. Eriksson LS, Brundin T, Söderlund C, Wahren J. Hemodynamic effects of a long-acting somatostatin analogue in patients with liver cirrhosis. Scand J Gastroenterol 1987; 22: 919-25.
12. McKee R. A study of octreotide in oesophageal varices. Digestion 1990; 45: 60-5.
13. MacCormick PA, Dick R, Siringo S, Wagstaff D, Chesta J, McIntyre N, et al. Octreotide reduces azygos blood flow in cirrhotic patients with portal hypertension. Eur J Gastroenterol Hepatol 1990; 2: 489-92.
14. Lin HC, Tsai YT, Lee FY, Lee SD, Hsia HC, Lin WJ, et al. Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis. Gastroenterology 1992; 103: 229-34.
15. Primignani M, Vazzoler MC, Carpinelli L, Nolte A, Hall de Lima MC, Arcidiacono PG, et al. The effect of octreotide in intraesophageal variceal pressure in liver cirrhosis is unpredictable. Hepatology 1990; 12: 989.
16. Bosch J, Bordas JM, Rigau J, Viola C, Mastai R, Kravetz D, et al. Noninvasive measurement of the pressure of esophageal varices using an endoscopic gauge: comparison with measurements by variceal puncture in patients undergoing endoscopic sclerotherapy. Hepatology 1986; 6: 667-72.
17. Hosking SW, Robinson P, Johnson AG. Effect of Valsalva's manoeuvre and hyoscinbutylbromide on the pressure gradient across the wall of oesophageal varices. Gut 1987; 28: 1151-6.
18. Staritz M, Poralla T, Meyer zum Büschenfelde KH. Intravascular oesophageal variceal pressure (IOVP) assessed by endocopic fine needle puncture under basal conditions, Valsalva's manoeuvre and after glyceryltrinitrate application. Gut 1985; 26: 525-30.
19. Mosimann R. Nonaggressive assessment of portal hypertension using endoscopic measurement of variceal pressure. Am J Surg 1982; 143: 212-4.
20. Kapicioglu S, Ovali E, Yesildag O, Baki AH. Effects of somatostatin on portal venous velocity in cirrhotic patients: a placebo-controlled trial. Gastroenterology 1992; 3: 22-6.
21. Hwang SJ, Lin HC, Chang CF, Lee FY, Lu CW, Hsia HC, et al. A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding. J Hepatol 1992; 16: 320-5.
22. Silvain C, Carpentier S, Sautereau D, Czernichow B, Métreau JM, Fort E, et al. Terlipressin plus transdermal nitroglycerin vs octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial. Hepatology 1993; 18: 61-5.
23. Sung JJ, Chung SCS, Lai CW, Chan FKL, Leung JWC, Yung MY. Octreotide infusion or emergency sclerotherapy for variceal hemorrhage. Lancet 1993; 342: 637-41.
24. Kleber G, Sauerbruch T, Fisher G, Paumgartner G. Somatostatin does not reduce oesophageal variceal pressure in liver cirrhotics. Gut 1988; 29: 153-6.